ストックスクリーナーアプリを入手
12.79
0.63%
0.0808
前日終値:
$12.71
開ける：
$12.6
24時間の取引高:
315.88K
Relative Volume:
0.13
時価総額：
$4.08B
収益：
$3.02B
当期純損益:
$127.93M
株価収益率:
57.80
EPS:
0.2213
ネットキャッシュフロー:
$225.64M
1週間 パフォーマンス:
+2.48%
1か月 パフォーマンス:
-3.47%
6か月 パフォーマンス:
+24.30%
1年 パフォーマンス:
+72.14%
1日の値動き範囲:
$12.52
$12.80
1週間の範囲:
$12.01
$12.80
52週間の値動き範囲:
$6.685
$15.42
Amneal Pharmaceuticals Inc Stock (AMRX) Company Profile
名前
Amneal Pharmaceuticals Inc
セクター
電話
908-947-3120
住所
400 Crossing Boulevard, 3rd Floor, Bridgewater
Compare AMRX vs TAK, ZTS, HLN, TEVA, UTHR
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AMRX
Amneal Pharmaceuticals Inc
|
12.78 | 4.05B | 3.02B | 127.93M | 225.64M | 0.2213 |
TAK
Takeda Pharmaceutical Co Adr
|
18.54 | 58.95B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
119.52 | 50.55B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
10.01 | 44.44B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
30.73 | 35.54B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
577.96 | 25.49B | 3.18B | 1.33B | 1.04B | 27.90 |
Amneal Pharmaceuticals Inc Stock (AMRX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-09 | 開始されました | Barclays | Overweight |
| 2025-06-06 | 開始されました | Goldman | Buy |
| 2025-02-24 | アップグレード | JP Morgan | Neutral → Overweight |
| 2024-09-06 | アップグレード | JP Morgan | Underweight → Neutral |
| 2021-04-07 | 再開されました | RBC Capital Mkts | Sector Perform |
| 2021-03-08 | アップグレード | Goldman | Sell → Buy |
| 2020-12-14 | アップグレード | Barclays | Equal Weight → Overweight |
| 2020-12-14 | アップグレード | Guggenheim | Neutral → Buy |
| 2020-07-27 | 開始されました | Goldman | Sell |
| 2020-05-12 | アップグレード | Guggenheim | Sell → Neutral |
| 2019-12-12 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2019-11-12 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2019-11-07 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2019-07-22 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2019-07-11 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2019-07-08 | アップグレード | Piper Jaffray | Neutral → Overweight |
| 2019-06-11 | 開始されました | Barclays | Equal Weight |
| 2019-05-21 | アップグレード | Raymond James | Mkt Perform → Strong Buy |
| 2019-03-20 | 開始されました | SunTrust | Buy |
| 2019-03-08 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2018-12-14 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2018-10-16 | ダウングレード | SunTrust | Buy → Hold |
| 2018-08-13 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2018-07-23 | 開始されました | Morgan Stanley | Overweight |
| 2018-06-22 | 開始されました | B. Riley FBR, Inc. | Buy |
すべてを表示
Amneal Pharmaceuticals Inc (AMRX) 最新ニュース
FDA sends latest Untitled Letters to Amneal, BioCorRx over brochures, websites - Medical Marketing and Media
Amneal Launches Bimatoprost Ophthalmic Solution, 0.01% - The Manila Times
Amneal rolls out generic glaucoma eye drop in a $719M U.S. market - Stock Titan
AMRX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Volatility Watch: Whats the fair value of Amneal Pharmaceuticals Inc stock2026 Historical Comparison & Proven Capital Preservation Tips - baoquankhu1.vn
Amneal marks Parkinson's Awareness Month, $2M donation - goSkagit
Amneal to Report First Quarter 2026 Results on May 1, 2026 - The Manila Times
May 1 before the bell: Amneal to post quarterly results - Stock Titan
Amneal Announces $2 Million Donation to Support Patient - GlobeNewswire
Trading Recap: Whats the fair value of Amneal Pharmaceuticals Inc stockRate Cut & Low Volatility Stock Recommendations - baoquankhu1.vn
Allspring Global Investments Holdings LLC Grows Stock Position in Amneal Pharmaceuticals, Inc. $AMRX - MarketBeat
Pharma News: Is Amneal Pharmaceuticals Inc in a long term uptrend2026 Geopolitical Influence & Technical Pattern Recognition Alerts - baoquankhu1.vn
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Receives Average Rating of "Buy" from Brokerages - MarketBeat
Amneal Pharmaceuticals Stock: Generic Drug Leader Faces Recall Challenges Amid Sector Growth Opportu - AD HOC NEWS
Tudor Investment Corp ET AL Takes Position in Amneal Pharmaceuticals, Inc. $AMRX - MarketBeat
JPMorgan Chase & Co. Has $7.72 Million Stock Position in Amneal Pharmaceuticals, Inc. $AMRX - MarketBeat
Amneal Pharmaceuticals, Inc. $AMRX Shares Bought by SG Americas Securities LLC - MarketBeat
Amneal Pharmaceuticals (AMRX) price target increased by 13.79% to 16.83 - msn.com
AMRX SEC FilingsAmneal Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Amneal (NYSE: AMRX) Co-CEO receives major performance-based RSU award - Stock Titan
[Form 4/A] Amneal Pharmaceuticals, Inc. Amended Insider Trading Activity - Stock Titan
Suboxone Market Size Forecasts 2026-2033: Analyzing Industry - openPR.com
Major holder Dipan Patel cuts Amneal Pharmaceuticals (AMRX) stake to 5.4% - Stock Titan
Vanguard (AMRX) disaggregates holdings, reports 0 Amneal shares after realignment - Stock Titan
Amneal Pharmaceuticals (NASDAQ: AMRX) posts 2025 growth and seeks backing for board slate - Stock Titan
Amneal Pharmaceuticals, Inc. $AMRX Shares Purchased by Assenagon Asset Management S.A. - MarketBeat
Amneal Pharmaceuticals stock gains momentum as Truist raises target to $17 amid analyst optimism - AD HOC NEWS
Oliver Luxxe Assets LLC Purchases New Position in Amneal Pharmaceuticals, Inc. $AMRX - MarketBeat
Amneal Pharmaceuticals, Inc. (AMRX) added to S&P SmallCap 600 Index, boosting investor visibility - msn.com
If You Invested $1,000 in Amneal Pharmaceuticals Inc (AMRX) - Stock Titan
Aug Selloffs: Whats the fair value of Amneal Pharmaceuticals Inc stock2026 Price Momentum & Technical Confirmation Trade Alerts - baoquankhu1.vn
How Amneal’s Margin-Focused 2026 Outlook and 2025 Results Could Impact Amneal Pharmaceuticals (AMRX) Investors - simplywall.st
AMRX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Are Options Traders Betting on a Big Move in Amneal Pharmaceuticals Stock? - MSN
Hydroxychloroquine Market Is Booming So Rapidly | Sanofi and Amneal Pharmaceuticals, LLC - openPR.com
A Look At Amneal Pharmaceuticals (AMRX) Valuation After Strong 2025 Results And 2026 Growth Guidance - Sahm
Stock Recap: Is Amneal Pharmaceuticals Inc in a long term uptrend2026 Fundamental Recap & Long-Term Investment Growth Plans - baoquankhu1.vn
Aug Analyst Calls: What are the future prospects of Amneal Pharmaceuticals IncPortfolio Gains Report & Weekly High Return Stock Opportunities - baoquankhu1.vn
Retail Surge: Will Amneal Pharmaceuticals Inc benefit from green energy policies2026 Winners & Losers & Community Verified Swing Trade Signals - baoquankhu1.vn
Amneal Pharmaceuticals: Flattish 2026 Revenue Growth Aside, Stock Still Looks A Buy (AMRX) - Seeking Alpha
Algert Global LLC Cuts Stock Position in Amneal Pharmaceuticals, Inc. $AMRX - MarketBeat
Amneal Recalls Three Lots Of UTI Drug Over Concerns of Microbial Contamination: Retail Sticks To Bearish Territory - MSN
Capula Management Ltd Buys New Shares in Amneal Pharmaceuticals, Inc. $AMRX - MarketBeat
AMRX PE Ratio & Valuation, Is AMRX Overvalued - Intellectia AI
Is Amneal Pharmaceuticals (AMRX) Pricing Reflect Its DCF Gap And Recent Share Slide - Yahoo Finance
Fed Meeting: Does Amneal Pharmaceuticals Inc stock have upside surprise potential2026 Weekly Recap & Community Consensus Trade Alerts - baoquankhu1.vn
Amneal Pharmaceuticals (NASDAQ:AMRX) Shares Down 5.5%Here's What Happened - MarketBeat
Amneal Pharmaceuticals Inc (AMRX) Shares Gap Down to $12.73 on M - GuruFocus
Q4 Earnings Roundup: Amneal (NASDAQ:AMRX) And The Rest Of The Generic Pharmaceuticals Segment - Yahoo Finance
What Amneal Pharmaceuticals (AMRX)'s Return to Profitability and 2026 Guidance Means For Shareholders - simplywall.st
Amneal Pharmaceuticals Conference: “Amneal 2.0” Targets 2026 Growth in Biosimilars, CREXONT and AvKARE Shift - MarketBeat
Amneal Pharmaceuticals Inc (AMRX) 財務データ
収益
当期純利益
現金流量
EPS
0.08%
1.74%
大文字化:
|
ボリューム (24 時間):